The gut microbiota: A treasure for human health

Biotechnology Advances

Volumn 34, Issue 7, 2016, Pages 1210-1224

  Li, Daotong ^a   Wang, Pan ^a   Wang, Pengpu ^a   Hu, Xiaosong ^a   Chen, Fang ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bacteria; Disease; Gut microbiota; Human health; Prebiotics; Probiotics

Indexed keywords

BACTERIA; BIOTECHNOLOGY; DISEASES;

FECAL MICROBIOTA; GUT MICROBIOTA; HUMAN HEALTH; NEUROLOGICAL DISEASE; PHYSIOLOGICAL ROLES; PREBIOTICS; PROBIOTICS; THERAPEUTIC STRATEGY;

HEALTH;

BACTERIUM; BIOTECHNOLOGY; DISEASE; DRUG; ELDERLY POPULATION; METABOLISM; MICROBIAL COMMUNITY; PHYSIOLOGICAL RESPONSE; PROBIOTICS; PUBLIC HEALTH; YOUNG POPULATION;

AGING; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; INTESTINE FLORA; METABOLIC DISORDER; MICROBIOLOGY; NEUROLOGIC DISEASE;

AGING; EVIDENCE-BASED MEDICINE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNE SYSTEM DISEASES; METABOLIC DISEASES; NERVOUS SYSTEM DISEASES;

EID: 84995328195     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.08.003     Document Type: Review

References (243)

1. Aas, J., Gessert, C.E., Bakken, J.S., Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin. Infect. Dis. 36 (2003), 580–585.
2. Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Björkstén, B., Engstrand, L., Jenmalm, M.C., Low diversity of the gut microbiota in infants with atopic eczema. Allergy. Clin. Immunol. 129 (2012), 434–440.
3. Abrahamsson, T.R., Jakobsson, H.E., Andersson, A.F., Björkstén, B., Engstrand, L., Jenmalm, M.C., Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 44 (2014), 842–850.
4. Amar, J., Chabo, C., Waget, A., Klopp, P., Vachoux, C., Bermúdez-Humarán, L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3 (2011), 559–572.
5. Araya, M.M.L., Reid, G., Sanders, M.E., Stanton, C., Guidelines for the Evaluation of Probiotics in Food, Jt. FAO/WHOWork. 2002, Group, London, Ontario.
6. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
7. Azad, M.B., Konya, T., Maughan, H., Guttman, D.S., Field, C.J., Chari, R.S., et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 185 (2013), 385–394.
8. Bäckhed, F., Ding, H., Wang, T., Hooper, L.V., Koh, G.Y., Nagy, A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15718–15723.
9. Bäckhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., Gordon, J.I., Host-bacterial mutualism in the human intestine. Science 307 (2005), 1915–1920.
10. Bäckhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 979–984.
11. Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 17 (2015), 690–703.
12. Bailey, M.T., Lubach, G.R., Coe, C.L., Prenatal stress alters bacterial colonization of the gut in infant monkeys. J. Pediatr. Gastroenterol. Nutr. 38 (2004), 414–421.
13. Bailey, M.T., Dowd, S.E., Galley, J.D., Hufnagle, A.R., Allen, R.G., Lyte, M., Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav. Immun. 25 (2011), 397–407.
14. Bajaj, J.S., Ridlon, J.M., Hylemon, P.B., Thacker, L.R., Heuman, D.M., Smith, S., et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver. Physiol. 302 (2012), G168–G175.
15. Bajaj, J.S., Heuman, D.M., Sanyal, A.J., Hylemon, P.B., Sterling, R.K., Stravitz, R.T., et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One, 8, 2013, e60042.
16. Bartosch, S., Fite, A., Macfarlane, G.T., McMurdo, M.E., Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70 (2004), 3575–3581.
17. Belenguer, A., Duncan, S.H., Calder, A.G., Holtrop, G., Louis, P., Lobley, G.E., et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl. Environ. Microbiol. 72 (2006), 3593–3599.
18. Belzer, C., de Vos, W.M., Microbes inside–from diversity to function: the case of Akkermansia. ISME J. 6 (2012), 1449–1458.
19. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609.
20. Bercik, P., Park, A.J., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 23 (2011), 1132–1139.
21. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479 (2011), 538–541.
22. Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5, 2010, e10667.
23. Bisgaard, H., Li, N., Bonnelykke, K., Chawes, B.L., Skov, T., Paludan-Müller, G., et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy. Clin. Immunol. 128 (2011), 646–652.
24. Bolte, E.R., Autism and Clostridium tetani. Med. Hypotheses 51 (1998), 133–144.
25. Bouskra, D., Brézillon, C., Bérard, M., Werts, C., Varona, R., Boneca, I.G., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456 (2008), 507–510.
26. Brandt, L.J., Aroniadis, O.C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107 (2012), 1079–1087.
27. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med., 6, 2014, 263ra158.
28. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 16050–16055.
29. Breton, J., Tennoune, N., Lucas, N., Francois, M., Legrand, R., Jacquemot, J., et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab. 23 (2015), 1–11.
30. Brown, A.J., Goldsworthy, S.M., Barnes, A.A., Eilert, M.M., Tcheang, L., Daniels, D., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278 (2003), 11312–11319.
31. Brown, C.T., Davis-Richardson, A.G., Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One, 6, 2011, e25792.
32. Browne, H.P., Forster, S.C., Anonye, B.O., Kumar, N., Neville, B.A., Stares, M.D., et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature, 2016, 10.1038/nature17645.
33. Brugman, S., Klatter, F.A., Visser, J.T., Wildeboer-Veloo, A.C., Harmsen, H.J., Rozing, J., et al. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia 49 (2006), 2105–2108.
34. Buffie, C.G., Bucci, V., Stein, R.R., McKenney, P.T., Ling, L., Gobourne, A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517 (2015), 205–208.
35. Cabreiro, F., Au, C., Leung, K.Y., Vergara-Irigaray, N., Cochemé, H.M., Noori, T., et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153 (2013), 228–239.
36. Cani, P.D., Knauf, C., Iglesias, M.A., Drucker, D.J., Delzenne, N.M., Burcelin, R., Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55 (2006), 1484–1490.
37. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
38. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 (2007), 2374–2383.
39. Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
40. Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90 (2009), 1236–1243.
41. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
42. Cardwell, C.R., Stene, L.C., Joner, G., Cinek, O., Svensson, J., Goldacre, M.J., et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 51 (2008), 726–735.
43. Carvalho, F.A., Koren, O., Goodrich, J.K., Johansson, M.E., Nalbantoglu, I., Aitken, J.D., et al. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12 (2012), 139–152.
44. Catry, E., Pachikian, B.D., Salazar, N., Neyrinck, A.M., Cani, P.D., Delzenne, N.M., Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism. Life Sci. 132 (2015), 77–84.
45. Chang, C.J., Lin, C.S., Lu, C.C., Martel, J., Ko, Y.F., Ojcius, D.M., et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat. Commun., 6, 2015, 7489.
46. Charbonneau, M.R., O'Donnell, D., Blanton, L.V., Totten, S.M., Davis, J.C., Barratt, M.J., et al. Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164 (2016), 859–871.
47. Chassaing, B., Koren, O., Carvalho, F.A., Ley, R.E., Gewirtz, A.T., AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 63 (2014), 1069–1080.
48. Chassaing, B., Ley, R.E., Gewirtz, A.T., Intestinal epithelial cell Toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology 147 (2014), 1363–1377.
49. Chou, H.H., Chien, W.H., Wu, L.L., Cheng, C.H., Chung, C.H., Horng, J.H., et al. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 2175–2180.
50. Claesson, M.J., Cusack, S., O'Sullivan, O., Greene-Diniz, R., de Weerd, H., Flannery, E., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4586–4591.
51. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
52. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 18 (2013), 666–673.
53. Clayton, T.A., Baker, D., Lindon, J.C., Everett, J.R., Nicholson, J.K., Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 14728–14733.
54. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., et al. Dietary intervention impact on gut microbial gene richness. Nature 500 (2013), 585–588.
55. Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J. Clin. Invest. 123 (2013), 700–711.
56. Coyte, K.Z., Schluter, J., Foster, K.R., The ecology of the microbiome: networks, competition, and stability. Science 350 (2015), 663–666.
57. Cullender, T.C., Chassaing, B., Janzon, A., Kumar, K., Muller, C.E., Werner, J.J., et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 14 (2013), 571–581.
58. Dapito, D.H., Mencin, A., Gwak, G.Y., Pradere, J.P., Jang, M.K., Mederacke, I., et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21 (2012), 504–516.
59. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
60. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14691–14696.
61. de Goffau, M.C., Luopajärvi, K., Knip, M., Ilonen, J., Ruohtula, T., Härkönen, T., et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62 (2013), 1238–1244.
62. de Goffau, M.C., Fuentes, S., van den Bogert, B., Honkanen, H., de Vos, W.M., Welling, G.W., et al. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57 (2014), 1569–1577.
63. De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A.J., Green, W., et al. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat. Commun., 6, 2015, 7735.
64. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156 (2014), 84–96.
65. Derrien, M., Vaughan, E.E., Plugge, C.M., de Vos, W.M., Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54 (2004), 1469–1476.
66. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 43 (2008), 164–174.
67. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
68. Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., Microbiota is essential for social development in the mouse. Mol. Psychiatry 19 (2014), 146–148.
69. Di Bella, S., Gouliouris, T., Petrosillo, N., Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients. J. Infect. Chemother. 21 (2015), 230–237.
70. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 3047–3052.
71. DiGiulio, D.B., Romero, R., Amogan, H.P., Kusanovic, J.P., Bik, E.M., Gotsch, F., et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS One, 3, 2008, e3056.
72. Dominguez-Bello, M.G., Costello, E.K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 11971–11975.
73. Dumas, M.E., Barton, R.H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 12511–12516.
74. Duncan, S.H., Lobley, G.E., Holtrop, G., Ince, J., Johnstone, A.M., Louis, P., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 32 (2008), 1720–1724.
75. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
76. Ege, M.J., Mayer, M., Normand, A.C., Genuneit, J., Cookson, W.O., Braun-Fahrländer, C., et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 364 (2011), 701–709.
77. Eiseman, B., Silen, W., Bascom, G.S., Kauvar, A.J., Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44 (1958), 854–859.
78. Endesfelder, D., zu Castell, W., Ardissone, A., Davis-Richardson, A.G., Achenbach, P., Hagen, M., et al. Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63 (2014), 2006–2014.
79. Erny, D., Hrabě de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18 (2015), 965–977.
80. Evans, W.E., Relling, M.V., Moving towards individualized medicine with pharmacogenomics. Nature 429 (2004), 464–468.
81. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (2011), 2775–2786.
82. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9066–9071.
83. Everard, A., Lazarevic, V., Gaïa, N., Johansson, M., Ståhlman, M., Backhed, F., et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8 (2014), 2116–2130.
84. Ewaschuk, J., Endersby, R., Thiel, D., Diaz, H., Backer, J., Ma, M., et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46 (2007), 841–850.
85. Faa, G., Gerosa, C., Fanni, D., Nemolato, S., van Eyken, P., Fanos, V., Factors influencing the development of a personal tailored microbiota in the neonate, with particular emphasis on antibiotic therapy. J. Matern. Fetal. Neonatal. Med. 26 (2013), 35–43.
86. Fagarasan, S., Muramatsu, M., Suzuki, K., Nagaoka, H., Hiai, H., Honjo, T., Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298 (2002), 1424–1427.
87. Finegold, S.M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M.L., Bolte, E., et al. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35 (2002), S6–S16.
88. Finegold, S.M., Dowd, S.E., Gontcharova, V., Liu, C., Henley, K.E., Wolcott, R.D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16 (2010), 444–453.
89. Finegold, S.M., Downes, J., Summanen, P.H., Microbiology of regressive autism. Anaerobe 18 (2012), 260–262.
90. Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
91. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 13780–13785.
92. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 (2011), 543–547.
93. Gareau, M.G., Wine, E., Rodrigues, D.M., Cho, J.H., Whary, M.T., Philpott, D.J., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60 (2011), 307–317.
94. Gaykema, R.P., Goehler, L.E., Lyte, M., Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav. Immun. 18 (2004), 238–245.
95. Geurts, L., Everard, A., Van Hul, M., Essaghir, A., Duparc, T., Matamoros, S., et al. Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nat. Commun., 6, 2015, 6495.
96. Gibson, G.R., Roberfroid, M.B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 125 (1995), 1401–1412.
97. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., et al. Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359.
98. Giongo, A., Gano, K.A., Crabb, D.B., Mukherjee, N., Novelo, L.L., Casella, G., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5 (2011), 82–91.
99. Goehler, L.E., Gaykema, R.P., Opitz, N., Reddaway, R., Badr, N., Lyte, M., Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 19 (2005), 334–344.
100. Goehler, L.E., Park, S.M., Opitz, N., Lyte, M., Gaykema, R.P., Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav. Immun. 22 (2008), 354–366.
101. Gómez-Hurtado, I., Santacruz, A., Peiró, G., Zapater, P., Gutiérrez, A., Pérez-Mateo, M., et al. Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoS One, 6, 2011, e23037.
102. Goodman, A.L., Kallstrom, G., Faith, J.J., Reyes, A., Moore, A., Dantas, G., et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 6252–6257.
103. Guarner, C., González-Navajas, J.M., Sánchez, E., Soriando, G., Francés, R., Chiva, M., et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 44 (2006), 633–639.
104. Gupta, A., Dhiman, R.K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J. Hepatol. 53 (2010), 849–855.
105. Hansen, C.H., Krych, L., Nielsen, D.S., Vogensen, F.K., Hansen, L.H., Sørensen, S.J., et al. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55 (2012), 2285–2294.
106. Hara, N., Alkanani, A.K., Ir, D., Robertson, C.E., Wagner, B.D., Frank, D.N., et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J. Immunol. 189 (2012), 3805–3814.
107. Hashemi, A., Villa, C.R., Comelli, E.M., Probiotics in early life: a preventative and treatment approach. Food Funct. 7 (2016), 1752–1768.
108. Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W.Z., Strowig, T., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482 (2012), 179–185.
109. Hopkins, M.J., Macfarlane, G.T., Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. Microbiol. 51 (2002), 448–454.
110. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
111. Human Microbiome Project Consortium, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
112. Hwang, J.S., Im, C.R., Im, S.H., Immune disorders and its correlation with gut microbiome. Immune. Netw. 12 (2012), 129–138.
113. Islam, K.B., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141 (2011), 1773–1781.
114. Jakobsson, H.E., Abrahamsson, T.R., Jenmalm, M.C., Harris, K., Quince, C., Jernberg, C., et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut 63 (2014), 559–566.
115. Jeffery, I.B., O'Toole, P.W., Öhman, L., Claesson, M.J., Deane, J., Quigley, E.M., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012), 997–1006.
116. Jia, W., Li, H., Zhao, L., Nicholson, J.K., Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7 (2008), 123–129.
117. Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep., 5, 2015, 8096.
118. Jiménez, E., Fernández, L., Marín, M.L., Martín, R., Odriozola, J.M., Nueno-Palop, C., et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr. Microbiol. 51 (2005), 270–274.
119. Jiménez, E., Marín, M.L., Martín, R., Odriozola, J.M., Olivares, M., Xaus, J., et al. Is meconium from healthy newborns actually sterile?. Res. Microbiol. 159 (2008), 187–193.
120. Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60 (2011), 631–637.
121. Kaddurah-Daouk, R., Baillie, R.A., Zhu, H., Zeng, Z.B., Wiest, M.M., Nguyen, U.T., et al. Enteric microbiome metabolites correlate with response to simvastatin treatment. PLoS One, 6, 2011, e25482.
122. Kakiyama, G., Pandak, W.M., Gillevet, P.M., Hylemon, P.B., Heuman, D.M., Daita, K., et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58 (2013), 949–955.
123. Kalambokis, G.N., Mouzaki, A., Rodi, M., Pappas, K., Fotopoulos, A., Xourgia, X., et al. Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin. Gastroenterol. Hepatol. 10 (2012), 815–818.
124. Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
125. Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 17193–17198.
126. Karlsson, F.H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun., 3, 2012, 1245.
127. Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
128. Kawamoto, S., Tran, T.H., Maruya, M., Suzuki, K., Doi, Y., Tsutsui, Y., et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336 (2012), 485–489.
129. Kawamoto, S., Maruya, M., Kato, L.M., Suda, W., Atarashi, K., Doi, Y., et al. Foxp3(+) T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41 (2014), 152–165.
130. Kelly, C.R., de Leon, L., Jasutkar, N., Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J. Clin. Gastroenterol. 46 (2012), 145–149.
131. Kerckhoffs, A.P., Ben-Amor, K., Samsom, M., van der Rest, M.E., de Vogel, J., Knol, J., et al. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J. Med. Microbiol. 60 (2011), 236–245.
132. Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun., 4, 2013, 1829.
133. Koenig, J.E., Spor, A., Scalfone, N., Fricker, A.D., Stombaugh, J., Knight, R., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4578–4585.
134. Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol., 9, 2009, 95.
135. Kubinak, J.L., Petersen, C., Stephens, W.Z., Soto, R., Bake, E., O'Connell, R.M., et al. MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17 (2015), 153–163.
136. Lamontagne, A., Long, R.E., Comunale, M.A., Hafner, J., Rodemich-Betesh, L., Wang, M., et al. Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection. PLoS One, 8, 2013, e64992.
137. Larsen, N., Vogensen, F.K., van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085.
138. Larsson, E., Tremaroli, V., Lee, Y.S., Koren, O., Nookaew, I., Fricker, A., et al. Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 61 (2012), 1124–1131.
139. Lawley, T.D., Clare, S., Walker, A.W., Stares, M.D., Connor, T.R., Raisen, C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog., 8, 2012, e1002995.
140. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
141. Le Poul, E., Loison, C., Struyf, S., Springael, J.Y., Lannoy, V., Decobecq, M.E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278 (2003), 25481–25489.
142. Lee, Y.K., Menezes, J.S., Umesaki, Y., Mazmanian, S.K., Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4615–4622.
143. Ley, R.E., Bäckhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 11070–11075.
144. Ley, R.E., Peterson, D.A., Gordon, J.I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006), 837–848.
145. Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity. Nature 444 (2006), 1022–1023.
146. Ley, R.E., Hamady, M., Lozupone, C., Turnbaugh, P.J., Ramey, R.R., Bircher, J.S., et al. Evolution of mammals and their gut microbes. Science 320 (2008), 1647–1651.
147. Lin, A., Bik, E.M., Costello, E.K., Dethlefsen, L., Haque, R., Relman, D.A., et al. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS One, 8, 2013, e53838.
148. Liu, C.H., Lee, S.M., Vanlare, J.M., Kasper, D.L., Mazmanian, S.K., Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 3951–3956.
149. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F., Spiller, R.C., Functional bowel disorders. Gastroenterology 130 (2006), 1480–1491.
150. Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
151. Lyra, A., Rinttilä, T., Nikkilä, J., Krogius-Kurikka, L., Kajander, K., Malinen, E., et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J. Gastroenterol. 15 (2009), 5936–5945.
152. Malinen, E., Rinttilä, T., Kajander, K., Mättö, J., Kassinen, A., Krogius, L., et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 100 (2005), 373–382.
153. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55 (2006), 205–211.
154. Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol., 9, 2009, 123.
155. Martínez, I., Stegen, J.C., Maldonado-Gómez, M.X., Eren, A.M., Siba, P.M., Greenhill, A.R., et al. The gut microbiota of rural Papua new guineans: composition, diversity patterns, and ecological processes. Cell Rep. 11 (2015), 527–538.
156. Maslowski, K.M., Vieira, A.T., Ng, A., Kranich, J., Sierro, F., Yu, D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 (2009), 1282–1286.
157. Mejía-León, M.E., Petrosino, J.F., Ajami, N.J., Domínguez-Bello, M.G., de la Barca, A.M., Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci. Rep., 4, 2014, 3814.
158. Muccioli, G.G., Naslain, D., Bäckhed, F., Reigstad, C.S., Lambert, D.M., Delzenne, N.M., et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol., 6, 2010, 392.
159. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72 (2006), 1027–1033.
160. Munyaka, P.M., Khafipour, E., Ghia, J.E., External influence of early childhood establishment of gut microbiota and subsequent health implications. Front. Pediatr., 2, 2014, 109.
161. Murri, M., Leiva, I., Gomez-Zumaquero, J.M., Tinahones, F.J., Cardona, F., Soriguer, F., et al. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med., 11, 2013, 46.
162. Napolitano, A., Miller, S., Nicholls, A.W., Baker, D., Van, H.S., Thomas, E., et al. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One, 9, 2014, e100778.
163. Neal, M.D., Leaphart, C., Levy, R., Prince, J., Billiar, T.R., Watkins, S., et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 176 (2006), 3070–3079.
164. Ochoa-Repáraz, J., Mielcarz, D.W., Ditrio, L.E., Burroughs, A.R., Begum-Haque, S., Dasgupta, S., et al. Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J. Immunol. 185 (2010), 4101–4108.
165. O'Mahony, S.M., Marchesi, J.R., Scully, P., Codling, C., Ceolho, A.M., Quigley, E.M., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 65 (2009), 263–267.
166. Palm, N.W., de Zoete, M.R., Cullen, T.W., Barry, N.A., Stefanowski, J., Hao, L., et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158 (2014), 1000–1010.
167. Palmer, C., Bik, E.M., DiGiulio, D.B., Relman, D.A., Brown, P.O., Development of the human infant intestinal microbiota. PLoS Biol., 5, 2007, e177.
168. Park, A.J., Collins, J., Blennerhassett, P.A., Ghia, J.E., Verdu, E.F., Bercik, P., et al. Altered colonic function and microbiota profile in a mouse model of chronic depression. Neurogastroenterol. Motil., 25, 2013, 733, e575.
169. Parnell, J.A., Reimer, R.A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 89 (2009), 1751–1759.
170. Parracho, H.M., Bingham, M.O., Gibson, G.R., McCartney, A.L., Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54 (2005), 987–991.
171. Penders, J., Thijs, C., Vink, C., Stelma, F.F., Snijders, B., Kummeling, I., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118 (2006), 511–521.
172. Peng, J., Narasimhan, S., Marchesi, J.R., Benson, A., Wong, F.S., Wen, L., Long term effect of gut microbiota transfer on diabetes development. J. Autoimmun. 53 (2014), 85–94.
173. Peterson, D.A., McNulty, N.P., Guruge, J.L., Gordon, J.I., IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2 (2007), 328–339.
174. Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.J., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 15813–15818.
175. Png, C.W., Lindén, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105 (2010), 2420–2428.
176. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
177. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
178. Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513 (2014), 59–64.
179. Rajilić-Stojanović, M., Biagi, E., Heilig, H.G., Kajander, K., Kekkonen, R.A., Tims, S., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141 (2011), 1792–1801.
180. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
181. Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog., 1, 2009, 6.
182. Reyes, A., Haynes, M., Hanson, N., Angly, F.E., Heath, A.C., Rohwer, F., et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466 (2010), 334–338.
183. Ridlon, J.M., Kang, D.J., Hylemon, P.B., Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47 (2006), 241–259.
184. Rinttilä, T., Lyra, A., Krogius-Kurikka, L., Palva, A., Real-time PCR analysis of enteric pathogens from fecal samples of irritable bowel syndrome subjects. Gut Pathog., 3, 2011, 6.
185. Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 104 (2010), S1–63.
186. Roesch, L.F., Lorca, G.L., Casella, G., Giongo, A., Naranjo, A., Pionzio, A.M., et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J. 3 (2009), 536–548.
187. Rossen, N.G., MacDonald, J.K., de Vries, E.M., D'Haens, G.R., de Vos, W.M., Zoetendal, E.G., et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J. Gastroenterol. 21 (2015), 5359–5371.
188. Rosser, E.C., Oleinika, K., Tonon, S., Doyle, R., Bosma, A., Carter, N.A., et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat. Med. 20 (2014), 1334–1339.
189. Round, J.L., Lee, S.M., Li, J., Tran, G., Jabri, B., Chatila, T.A., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332 (2011), 974–977.
190. Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11 (2010), 76–83.
191. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 16767–16772.
192. Santacruz, A., Collado, M.C., García-Valdés, L., Segura, M.T., Martín-Lagos, J.A., Anjos, T. et al., Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104 (2010), 83–92.
193. Satokari, R., Grönroos, T., Laitinen, K., Salminen, S., Isolauri, E., Bifidobacterium and Lactobacillus DNA in the human placenta. Lett. Appl. Microbiol. 48 (2009), 8–12.
194. Sayin, S.I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.U., Bamberg, K., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17 (2013), 225–235.
195. Schnorr, S.L., Candela, M., Rampelli, S., Centanni, M., Consolandi, C., Basaglia, G., et al. Gut microbiome of the Hadza hunter-gatherers. Nat. Commun., 5, 2014, 3654.
196. Schwan, A., Sjölin, S., Trottestam, U., Aronsson, B., Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet, 2, 1983, 845.
197. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N.A., Donus, C., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18 (2010), 190–195.
198. Scott, K.P., Martin, J.C., Chassard, C., Clerget, M., Potrykus, J., Campbell, G., et al. Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and starch. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4672–4679.
199. Shin, N.R., Lee, J.C., Lee, H.Y., Kim, M.S., Whon, T.W., Lee, M.S., et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63 (2014), 727–735.
200. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 16731–16736.
201. Song, Y., Liu, C., Finegold, S.M., Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70 (2004), 6459–6465.
202. Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
203. Suárez-Zamorano, N., Fabbiano, S., Chevalier, C., Stojanović, O., Colin, D.J., Stevanović, A., et al. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat. Med. 21 (2015), 1497–1501.
204. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 558 (2004), 263–275.
205. Suzuki, K., Meek, B., Doi, Y., Muramatsu, M., Chiba, T., Honjo, T., et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 1981–1986.
206. Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368 (2013), 1575–1584.
207. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S.I., Kuwahara, A., Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 59 (2008), 251–262.
208. Thavagnanam, S., Fleming, J., Bromley, A., Shields, M.D., Cardwell, C.R., A meta-analysis of the association between caesarean section and childhood asthma. Clin. Exp. Allergy 38 (2008), 629–633.
209. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
210. Turnbaugh, P.J., Bäckhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
211. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
212. Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334 (2011), 255–258.
213. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., de Vos, W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368 (2013), 407–415.
214. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
215. Vulevic, J., Drakoularakou, A., Yaqoob, P., Tzortzis, G., Gibson, G.R., Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am. J. Clin. Nutr. 88 (2008), 1438–1446.
216. Walker, A.W., Ince, J., Duncan, S.H., Webster, L.M., Holtrop, G., Ze, X., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5 (2011), 220–230.
217. Walker, A.W., Duncan, S.H., Louis, P., Flint, H.J., Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22 (2014), 267–274.
218. Walton, G.E., van den Heuvel, E.G., Kosters, M.H., Rastall, R.A., Tuohy, K.M., Gibson, G.R., A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br. J. Nutr. 107 (2012), 1466–1475.
219. Wang, B., Mao, Y.K., Diorio, C., Pasyk, M., Wu, R.Y., Bienenstock, J., et al. Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes. FASEB J. 24 (2010), 4078–4088.
220. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
221. Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl. Environ. Microbiol. 77 (2011), 6718–6721.
222. Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 9 (2015), 1–15.
223. Wang, Z., Roberts, A.B., Buffa, J.A., Levison, B.S., Zhu, W., Org, E., et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163 (2015), 1585–1595.
224. Wei, X., Yan, X., Zou, D., Yang, Z., Wang, X., Liu, W., et al. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach. BMC Gastroenterol., 13, 2013, 175.
225. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
226. Williams, B.L., Hornig, M., Parekh, T., Lipkin, W.I., Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio. 3 (2012), e00261–e002611.
227. Willing, B.P., Dicksved, J., Halfvarson, J., Andersson, A.F., Lucio, M., Zheng, Z., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139 (2010), 1844–1854.
228. Woodmansey, E.J., McMurdo, M.E., Macfarlane, G.T., Macfarlane, S., Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl. Environ. Microbiol. 70 (2004), 6113–6122.
229. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
230. Xiao, L., Feng, Q., Liang, S., Sonne, S.B., Xia, Z., Qiu, X., et al. A catalog of the mouse gut metagenome. Nat. Biotechnol. 33 (2015), 1103–1108.
231. Xie, W., Gu, D., Li, J., Cui, K., Zhang, Y., Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS One, 6, 2011, e24520.
232. Xu, J., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J. 9 (2015), 552–562.
233. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
234. Youngster, I., Sauk, J., Pindar, C., Wilson, R.G., Kaplan, J.L., Smith, M.B., et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin. Infect. Dis. 58 (2014), 1515–1522.
235. Yu, L.X., Yan, H.X., Liu, Q., Yang, W., Wu, H.P., Dong, W., et al. Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52 (2010), 1322–1333.
236. Zhang, X., Zhao, Y., Zhang, M., Pang, X., Xu, J., Kang, C., et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One, 7, 2012, e42529.
237. Zhang, F., Luo, W., Shi, Y., Fan, Z., Ji, G., Should we standardize the 1700-year-old fecal microbiota transplantation?. Am. J. Gastroenterol., 107, 2012, 1755.
238. Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One, 8, 2013, e71108.
239. Zhang, H., Sparks, J.B., Karyala, S.V., Settlage, R., Luo, X.M., Host adaptive immunity alters gut microbiota. ISME J. 9 (2015), 770–781.
240. Zhao, L., The gut microbiota and obesity: from correlation to causality. Nat. Rev. Microbiol. 11 (2013), 639–647.
241. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.
242. Zivkovic, A.M., German, J.B., Lebrilla, C.B., Mills, D.A., Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 4653–4658.
243. Zwielehner, J., Liszt, K., Handschur, M., Lassl, C., Lapin, A., Haslberger, A.G., Combined PCR-DGGE fingerprinting and quantitative-PCR indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Exp. Gerontol. 44 (2009), 440–446.